ASCO 2019: First-line pembrolizumab for advanced kidney cancer
Two presentations on the results of the KEYNOTE-427 clinical trial [...]
Two presentations on the results of the KEYNOTE-427 clinical trial [...]
The following presentation from the American Society of Clinical Oncology [...]
A recent study by researchers in New York, USA, and [...]
Results from a first-in-human phase 1 study of savolitinib in [...]
A recent study published in Scientific Reports last month has [...]
A recent study, published in The Lancet Oncology, has provided [...]
The results from the following study were presented at the [...]
Results from this trial for patients with non-clear cell renal [...]
The results from the following study were presented at the [...]
A recent study reports the real-world safety and efficacy of [...]